Pipeline — registered trials by phase
An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer
— · Colorectal Cancer · Active Not Recruiting · est. 2027-09-30
OTIS Vedolizumab Pregnancy Exposure Registry
— · Colitis, Ulcerative, Crohn's Disease · Completed · est. 2022-07-15
Epidemiology of Narcolepsy Type 1 and Type 2 in Spain
— · Narcolepsy Type 1, Narcolepsy Type 2 · Active Not Recruiting · est. 2026-09-30
A Study to Monitor the Fruzaqla Treatment of Adults With Metastatic Colorectal Cancer (mCRC) in South Korea
— · Colorectal Cancer · Recruiting · est. 2029-09-01
Magnetic Resonance Imaging in Subjects With Gouty Tophi
— · Hyperuricemia, Gout · Completed · est. 2003-01
Ramelteon 8 mg Tablets Specified Drug-use Survey: <Long-term Survey on Insomnia Accompanied by Difficulty Falling Asleep> - Transitional Survey From the Preceding Drug-use Survey -
— · Insomnia · Completed · est. 2014-06
Treatment Preference for Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Versus Daily DPP-4 Inhibitors in Participants With Type 2 Diabetes Mellitus
— · Type 2 Diabetes Mellitus · Completed · est. 2018-02-09
A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life Practice
— · Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases · Completed · est. 2021-11-08
A Study to Observe the Safety and Efficacy of Vedolizumab in Biologically Naive Participants With Ulcerative Colitis (UC) or Crohn´s Disease (CD)
— · Crohn Disease, Colitis, Ulcerative, Inflammatory Bowel Diseases · Completed · est. 2020-08-31
A Survey of Recombinant ADAMTS13 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
— · Thrombotic Thrombocytopenic Purpura (TTP) · Recruiting · est. 2032-09-30
An Observational Study of Patient Cohorts Who Previously Received Long-term Treatment With Pioglitazone or Placebo in Addition to Existing Antidiabetic Medications
— · Diabetes Mellitus, Type 2 · Completed · est. 2011-11
A Study of NINLARO® in Chinese Adults With Multiple Myeloma
— · Multiple Myeloma · Active Not Recruiting · est. 2026-12-31
Paricipant Preferences in the Treatment of Inflammatory Bowel Disease (IBD) in Europe
— · Crohn Disease, Colitis, Ulcerative, Inflammatory Bowel Diseases · Completed · est. 2021-01-31
A Study of Teduglutide in Japanese People With Short Bowel Syndrome
— · Short Bowel Syndrome · Completed · est. 2026-07-31
A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma
— · Hodgkin Lymphoma · Recruiting · est. 2027-01-13
Pioglitazone Special Drug Use Surveillance "Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus"
— · Type 2 Diabetes Mellitus · Completed · est. 2013-06-30
Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes
— · Diabetes, Bladder Cancer · Completed · est. 2014-08
Instanyl® Non-Interventional Study
— · Breakthrough Cancer Pain · Completed · est. 2012-04
A Study of Brigatinib as Preferred First Therapy for Adults With Non-Small Cell Lung Cancer (NSCLC) ENTIRETY
— · Non-small Cell Lung Cancer (NSCLC) · Active Not Recruiting · est. 2027-04-26
A Study of Prucalopride in Breastfeeding Women With Constipation
— · Chronic Idiopathic Constipation (CIC) · Recruiting · est. 2027-10-31
Lansoprazole Intravenous 30 mg Specified Drug-use Survey [Hemostatic Effect/Rebleeding Rate]
— · Gastric Ulcer, Duodenal Ulcer, Acute Stress Gastritis, and Acute Gastric Mucosal Lesions · Completed · est. 2010-03
TAK-935 Multiple Rising Dose Study in Healthy Participants
— · Epilepsy · Completed · est. 2016-04
A Study of Vonoprazan in Adults With Helicobacter Pylori
— · Helicobacter Pylori · Completed · est. 2021-09-27
A Study of TAK-881 in Healthy Adults
— · Healthy Volunteers · Completed · est. 2022-04-12
TAK-438_110 Drug Interaction With Cytochrome P450 3A4 (CYP3A4) Inhibitor Clarithromycin
— · Healthy Volunteers · Completed · est. 2010-09
A Study of TAK-227 in Healthy Adults
— · Healthy Volunteers · Completed · est. 2023-06-19
A Study to Determine the Effect Food Has on TAK-721 (Budesonide Oral Suspension) in the Body of Healthy Adults
— · Healthy Volunteers · Completed · est. 2023-02-17
Food Effect Study of Febuxostat XR in Healthy Participants
— · Gout · Completed · est. 2015-03
A Study to Evaluate the Effect of the Potent Cytochrome P-450 3A4 (CYP3A4) Inhibitor Itraconazole on the Pharmacokinetics (PK) of TAK-954 in Healthy Adult Participants
— · Healthy Participants · Completed · est. 2017-07-24
Efficacy and Safety of Peginesatide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Participants Previously Treated With Epoetin.
— · Anemia · Completed · est. 2010-05
Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.
— · Congestive Heart Failure · Completed · est. 2003-08
A Study of TAK-019 in Healthy Japanese Adults (COVID-19)
— · Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) · Completed · est. 2022-03-28
An Extension Study of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase-IT in Conjunction With Elaprase in Pediatric Participants With Hunter Syndrome and Cognitive Impairment
— · Hunter Syndrome · Completed · est. 2024-04-30
A Study of TAK-079 in People With Generalized Myasthenia Gravis
— · Myasthenia Gravis · Completed · est. 2022-07-12
Long-term Safety Study of Alogliptin in Participants With Type 2 Diabetes in Japan
— · Type 2 Diabetes Mellitus · Completed · est. 2008-09
A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Renal Cell Carcinoma
— · Advanced Renal Cell Carcinoma · Completed · est. 2020-08-25
Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet
— · Celiac Disease · Completed · est. 2025-12-09
Safety and Efficacy of Ramelteon and Doxepin in Subjects With Chronic Insomnia
— · Sleep Initiation and Maintenance Disorders · Completed · est. 2007-03
A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma
— · Hodgkin Disease · Active Not Recruiting · est. 2020-05-05
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
— · Crohn's Disease, Ulcerative Colitis · Recruiting · est. 2029-12-30
Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan
— · Type 2 Diabetes Mellitus · Completed · est. 2008-04
Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout
— · Gout · Completed · est. 2015-11
A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in Japan
— · Dengue Fever · Completed · est. 2025-07-09
A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant
— · Multiple Myeloma, Autologous Stem Cell Transplant · Completed · est. 2018-04-16
Efficacy and Safety of Oral Febuxostat in Participants With Gout
— · Gout · Completed · est. 2008-03
Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese Patients
— · Heartburn, Gastroesophageal Reflux Disease · Completed · est. 2018-03-14
Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.
— · Chronic Insomnia · Completed · est. 2006-12
Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Participants With Erosive Esophagitis
— · Erosive Esophagitis · Completed · est. 2017-07-27
Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension
— · Essential Hypertension · Completed · est. 2009-11
TachoSil® Versus Surgicel® Original for the Secondary Treatment of Local Bleeding in Adult and Pediatric Patients Undergoing Hepatic Resection Surgery
— · Hemorrhage · Completed · est. 2013-05
Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis
— · Esophagitis, Reflux, Esophagitis, Peptic · Completed · est. 2007-05
Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis
— · Esophagitis, Reflux, Esophagitis, Peptic · Completed · est. 2007-01
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
— · Cardiovascular Disease · Completed · est. 2017-05-15
Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus
— · Diabetes Mellitus · Completed · est. 2009-05
Effect of Food on the Pharmacokinetics of Single Oral Dose Administration of a Fixed-Dose Combination of SYR-322 and Metformin Hydrochloride in Healthy Adult Male Subjects
— · Clinical Pharmacology · Completed · est. 2014-06
Safety and Efficacy Study of Ramelteon in Subjects With Chronic Insomnia
— · Sleep Initiation and Maintenance Disorders · Completed · est. 2008-03
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Takeda is lead sponsor; 56 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 6-K2026-09-14Report of foreign issuer
- 6-K2026-08-31Report of foreign issuer
- 6-K2026-08-06Report of foreign issuer
- 6-K2026-07-30Report of foreign issuer
- 6-K2026-07-09Report of foreign issuer
- 6-K2026-07-08Report of foreign issuer
- 6-K2026-06-29Report of foreign issuer
- 6-K2026-06-26Report of foreign issuer
- 6-K2026-06-24Report of foreign issuer
- 6-K2026-06-24Report of foreign issuer
- 6-K2026-06-24Report of foreign issuer
- IRANNOTICE2026-06-17IRANNOTICE
- 20-F2026-06-17Annual report (foreign)
- 6-K2026-06-09Report of foreign issuer
- 6-K2026-06-05Report of foreign issuer
- 6-K2026-06-05Report of foreign issuer
- 6-K2026-06-01Report of foreign issuer
- 6-K2026-05-26Report of foreign issuer
- 6-K2026-05-26Report of foreign issuer
- 6-K2026-05-26Report of foreign issuer
- 6-K2026-05-26Report of foreign issuer
- 6-K2026-05-26Report of foreign issuer
- SD2026-05-22SD
- 6-K2026-05-19Report of foreign issuer
- 6-K2026-05-13Report of foreign issuer
- 6-K2026-05-13Report of foreign issuer
- 6-K2026-03-30Report of foreign issuer
- 6-K2026-03-26Report of foreign issuer
- 6-K2026-03-25Report of foreign issuer
- 6-K2026-03-02Report of foreign issuer
- 6-K2026-02-10Report of foreign issuer
- 6-K2026-01-29Report of foreign issuer
- 6-K2025-12-18Report of foreign issuer
- SCHEDULE 13G/A2025-12-09SCHEDULE 13G/A
- 6-K2025-12-08Report of foreign issuer
- 6-K2025-11-28Report of foreign issuer
- 13F-HR2025-11-1313F-HR
- 6-K2025-10-30Report of foreign issuer
- 6-K2025-10-30Report of foreign issuer
- 6-K2025-10-30Report of foreign issuer
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.